Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02625480
Title A Multi-Center Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-4)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications

acute lymphoblastic leukemia

Therapies

axicabtagene ciloleucel

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.